FDA Authorizes Dual Sensing Technology from Abbott
The FDA has authorized dual glucose‑ketone sensing technology from Medtrade exhibitor Abbott.
August 27 2026Latest in: News
Resmed Appoints Lead Director
Carol Burt will succeed Ron Taylor, Resmed’s current lead director, who is not standing for reelection at the…
August 21 20262Q Sales Up at Medline
Net sales for the second quarter at Medtrade exhibitor Medline Inc. hit $7.7 billion, an increase of 11.6%.
August 16 2026
Drive Medical Appoints New Head of Respiratory Clinical Affairs
Medtrade exhibitor Drive Medical has appointed Chrysalis Ashton, MSRC, RRT, as head of Respiratory Clinical Affairs and Industry…
August 15 2026Revenue Up at Medtrade Exhibitor Resmed
Resmed results for the fourth quarter ended June 30, 2026 reflected a 9% revenue jump.
August 10 2026CMS Touts Major DME Fraud Reduction
CMS Deputy Administrator Kimberly Brandt declared that recent efforts have wiped out the majority of DME fraud in…
August 3 2026Cardinal Health Bolsters Diabetes, Urology Business
Medtrade exhibitor Cardinal Health has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy.
July 28 2026House Passes Wheelchair Legislation
The Choices for Increased Mobility Act has passed the U.S. House of Representatives and advanced to the Senate.
July 21 2026TCPA and Text Messages
A federal appellate ruling is making waves in the federal Telephone Consumer Protection Act (TCPA) space.
July 21 2026Annual Accreditation: Headache or Blessing?
The three-year accreditation cycle is no more, but is the annual re-survey a headache, a blessing, or something…
July 21 2026